Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Excelsior Medical Co stock price, quote, forecast and news

4104.TW
TW0004104005

Price

87.10
Today +/-
-0.03
Today %
-1.14 %
P

Excelsior Medical Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Excelsior Medical Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Excelsior Medical Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Excelsior Medical Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Excelsior Medical Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Excelsior Medical Co Stock Price History

DateExcelsior Medical Co Price
9/4/202487.10 undefined
9/3/202488.10 undefined
9/2/202488.30 undefined
8/30/202488.60 undefined
8/29/202488.00 undefined
8/28/202488.20 undefined
8/27/202488.60 undefined
8/26/202488.80 undefined
8/23/202487.24 undefined
8/22/202487.43 undefined
8/21/202487.62 undefined
8/20/202487.43 undefined
8/19/202487.24 undefined
8/16/202487.90 undefined
8/15/202487.90 undefined
8/14/202486.29 undefined
8/13/202485.62 undefined
8/12/202485.24 undefined
8/9/202483.33 undefined
8/8/202483.24 undefined

Excelsior Medical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Excelsior Medical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Excelsior Medical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Excelsior Medical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Excelsior Medical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Excelsior Medical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Excelsior Medical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Excelsior Medical Co’s growth potential.

Excelsior Medical Co Revenue, EBIT and net profit per share

DateExcelsior Medical Co RevenueExcelsior Medical Co EBITExcelsior Medical Co Net Income
2024e8.92 B undefined795.6 M undefined836.66 M undefined
20238.23 B undefined702.88 M undefined746.61 M undefined
20227.19 B undefined606.61 M undefined667.45 M undefined
20216.57 B undefined595.03 M undefined607.15 M undefined
20206.68 B undefined529.07 M undefined571.67 M undefined
20196.46 B undefined464.04 M undefined514.76 M undefined
20186.35 B undefined438.12 M undefined451.56 M undefined
20176.1 B undefined452.56 M undefined399.05 M undefined
20166.21 B undefined379.5 M undefined389.56 M undefined
20156.2 B undefined348.17 M undefined378.44 M undefined
20145.81 B undefined343.5 M undefined285.68 M undefined
20135.74 B undefined308 M undefined300 M undefined
20126 B undefined386 M undefined276 M undefined
20115.99 B undefined492 M undefined334 M undefined
201015.36 B undefined475 M undefined356 M undefined
200914.3 B undefined343 M undefined312 M undefined
20083.26 B undefined248 M undefined234 M undefined
20073.18 B undefined316 M undefined1.21 B undefined
20063.24 B undefined467 M undefined338 M undefined
20052.96 B undefined346 M undefined242 M undefined
20042.04 B undefined75 M undefined145 M undefined

Excelsior Medical Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (M)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e
1.221.311.622.042.963.243.183.2614.315.365.9965.745.816.26.216.16.356.466.686.577.198.238.92
-7.3024.0825.6945.109.59-2.102.55339.097.38-60.970.08-4.301.136.820.05-1.774.101.773.38-1.539.3314.578.31
22.1520.0316.9418.8731.3232.5827.3025.128.879.9423.7722.6520.1220.3219.8519.2919.7918.9019.1719.5720.9021.0720.27-
0.270.260.280.390.931.060.870.821.271.531.431.361.161.181.231.21.211.21.241.311.371.511.670
47412975346467316248343475492386308343348379452438464529595606702795
3.863.131.793.6811.6914.409.957.612.403.098.216.435.365.915.616.117.426.907.197.939.058.438.538.92
0.240.290.250.150.240.341.210.230.310.360.330.280.30.290.380.390.40.450.510.570.610.670.750.84
-17.28-12.98-41.5366.9039.67257.99-80.6633.3314.10-6.18-17.378.70-5.0032.632.912.5713.0313.9711.096.309.8811.8412.06
------------------------
------------------------
55607610110111310991102108120120120115.54120.61137.18137.35137.45137.45155.91156.49156.41156.260
------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Excelsior Medical Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Excelsior Medical Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                             
0.090.110.370.980.781.061.511.271.452.391.581.741.873.073.764.333.523.413.413.553.773.233.41
0.510.550.610.570.810.560.740.892.863.411.271.151.141.141.11.31.451.221.291.231.361.411.66
0.070.050.160.120.20.270.280.220.720.774.074.574.744.434.695.654.324.152.952.713.113.624.16
0.250.30.310.410.480.450.570.751.481.711.281.171.281.231.121.031.121.010.850.850.911.161.25
93465289189149721093934273233321966.87270.12137.38121.65151.4699.97156.22150.59109.55223.65
1.011.071.492.172.452.493.163.236.98.78.528.959.229.8710.9312.4410.539.948.618.59.319.5310.69
0.130.140.420.510.870.890.620.640.70.880.840.840.620.420.330.270.270.290.80.830.911.031.07
0.630.830.941.060.430.420.840.831.431.912.822.993.883.763.583.883.873.464.054.384.585.646.02
00050430532035413526.0914.519.4542.627.5918.3812.217.2731.9657.93
0000002120209797772725.1417.16.726.356.383.864.85.623.8716.91
00009980333322434350.9849.4337.0433.5533.2128.1127.8527.3927.7628.25
191829449882555175102173148361638.37700.1178.27197.04226.94249.67245.99255.73217.81194.65
0.780.981.391.661.541.471.541.542.242.993.994.144.974.924.694.394.424.045.155.55.86.957.39
1.792.042.883.833.993.964.74.779.1311.6912.5113.0914.1914.7915.6216.8314.9513.9813.761415.1116.4818.08
                                             
0.360.430.620.680.710.920.80.80.891.031.031.131.131.131.21.281.281.281.281.411.411.481.56
0.130.110.510.520.510.810.960.961.392.192.222.22.242.382.662.832.82.812.823.283.283.283.29
0.70.870.910.890.851.031.931.681.821.992.072.132.312.362.452.532.62.742.93.023.193.343.5
00-1-20-26142-521-46458304.82-68.36-170.31-273.38-61.54-107.9-199.37-260.44-104.16-122.2
00000097711062621000162.3655.2310.5534.9151.5585.29118.34201.65388.87
1.191.412.052.092.072.753.73.444.225.265.355.636.146.186.416.516.426.816.957.597.748.28.61
0.240.230.350.340.40.290.420.523.643.921.091.171.161.091.111.231.031.011.060.880.9510.97
1818184614312111111422025828526400212.0400000000
0.030.050.110.480.370.410.20.170.160.252.853.413.943.914.195.543.912.982.472.653.464.134.5
0.210000.040.050.040.080.310.671.30.941.121.660.890.911.161.111.210.40.480.541.13
1700000000151840234414.535.72.99310.88085.4782.6272.2490.8669.97
0.520.30.470.860.950.880.760.884.335.115.546.186.566.686.417.686.415.114.834.024.965.756.68
49303312795703000994407323311617.53536.63319.8400164.44225.46209.78182.05236.83
000000003117376576.38104.284.1385.58105.55115.73156.96176.7233.8235.07
3134364919115743465154575469259.52386.63432.63435.02426.9423.8122.5817.7817.316.31
0.080.340.350.840.890.160.040.050.150.510.80.420.150.351.030.840.520.530.30.40.40.430.49
0.60.640.821.711.841.030.80.924.485.616.336.616.717.037.448.526.935.645.134.425.366.197.17
1.792.042.873.793.913.794.514.378.710.8711.6812.2312.8513.2113.8515.0313.3412.4512.0812.0213.114.3915.78
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Excelsior Medical Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Excelsior Medical Co's financial health and stability.

Assets

Excelsior Medical Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Excelsior Medical Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Excelsior Medical Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Excelsior Medical Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
0.240.280.250.150.270.381.270.260.360.430.450.360.410.470.550.580.550.650.750.830.870.96
192323311151388093100100131130123123125968480160167202222
1-2-2-8-14-10-7-1353-6-70000000000
43-37-2983-156194-181-355291-534-1,061271-95213234-52-981-363555138109-240
-215-261-222-11831-22-1,04517-92-37-39-37-85-70-166-173-145-173-268-265-241-308
2390083212364133222526292319151910810
42419916613410718212688113108909910277999410297103109
0.090.010.020.130.250.680.120.010.69-0.03-0.530.720.360.740.740.45-0.490.191.190.870.950.64
-13-33-279-167-218-161-52-25-105-303-58-46-89-30-28-31-36-36-52-35-168-172
0.180.06-0.17-0.21-0.15-0.170.720.18-0.53-0.69-0.860.03-0.54-0.350.23-0.310.431.46-0.54-0.410.14-0.69
0.20.090.11-0.040.06-00.770.2-0.43-0.39-0.80.08-0.45-0.320.26-0.280.461.49-0.49-0.380.31-0.52
0000000000000000000000
-195200832-175-227-1841214826949-393-222210-1846245-350-394-888-4-27
00500-23091000603-18000299000058500
-0.24-0.050.390.71-0.37-0.29-0.54-0.260.031.680.58-0.590.130.06-0.03-0.08-0.3-1-0.88-0.6-0.59-0.63
0-2-26-11425-24898-19440-92-9458171135221-229-293-105166-95-112
-48-64-106-109-80-93-280-400-169-188-257-102-225-225-282-304-319-357-384-465-494-494
3022239627-280233301-63171948-789158-36464929-26-402626-271-210453-565
76.9-25.4-260.9-34.926.4522.463.3-11.8588.3-337.4-587.3671.2268.3706.58711.54418.61-524.26156.211,142.49834.4776.3464.62
0000000000000000000000

Excelsior Medical Co stock margins

The Excelsior Medical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Excelsior Medical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Excelsior Medical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Excelsior Medical Co's sales revenue. A higher gross margin percentage indicates that the Excelsior Medical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Excelsior Medical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Excelsior Medical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Excelsior Medical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Excelsior Medical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Excelsior Medical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Excelsior Medical Co Margin History

Excelsior Medical Co Gross marginExcelsior Medical Co Profit marginExcelsior Medical Co EBIT marginExcelsior Medical Co Profit margin
2024e20.28 %8.92 %9.38 %
202320.28 %8.54 %9.07 %
202221.07 %8.44 %9.29 %
202120.9 %9.05 %9.24 %
202019.57 %7.93 %8.56 %
201919.18 %7.19 %7.97 %
201818.9 %6.9 %7.12 %
201719.8 %7.42 %6.55 %
201619.3 %6.12 %6.28 %
201519.85 %5.61 %6.1 %
201420.34 %5.92 %4.92 %
201320.12 %5.36 %5.23 %
201222.65 %6.43 %4.6 %
201123.77 %8.21 %5.57 %
20109.94 %3.09 %2.32 %
20098.87 %2.4 %2.18 %
200825.12 %7.61 %7.18 %
200727.3 %9.95 %38.1 %
200632.58 %14.4 %10.42 %
200531.32 %11.69 %8.18 %
200418.87 %3.68 %7.11 %

Excelsior Medical Co Stock Sales Revenue, EBIT, Earnings per Share

The Excelsior Medical Co earnings per share therefore indicates how much revenue Excelsior Medical Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Excelsior Medical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Excelsior Medical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Excelsior Medical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Excelsior Medical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Excelsior Medical Co Revenue, EBIT and net profit per share

DateExcelsior Medical Co Sales per ShareExcelsior Medical Co EBIT per shareExcelsior Medical Co Earnings per Share
2024e54.57 undefined0 undefined5.12 undefined
202352.69 undefined4.5 undefined4.78 undefined
202245.95 undefined3.88 undefined4.27 undefined
202142 undefined3.8 undefined3.88 undefined
202042.82 undefined3.39 undefined3.67 undefined
201946.98 undefined3.38 undefined3.75 undefined
201846.16 undefined3.19 undefined3.29 undefined
201744.38 undefined3.29 undefined2.91 undefined
201645.24 undefined2.77 undefined2.84 undefined
201551.43 undefined2.89 undefined3.14 undefined
201450.26 undefined2.97 undefined2.47 undefined
201347.84 undefined2.57 undefined2.5 undefined
201249.99 undefined3.22 undefined2.3 undefined
201149.95 undefined4.1 undefined2.78 undefined
2010142.19 undefined4.4 undefined3.3 undefined
2009140.21 undefined3.36 undefined3.06 undefined
200835.79 undefined2.73 undefined2.57 undefined
200729.14 undefined2.9 undefined11.1 undefined
200628.71 undefined4.13 undefined2.99 undefined
200529.31 undefined3.43 undefined2.4 undefined
200420.2 undefined0.74 undefined1.44 undefined

Excelsior Medical Co business model

Excelsior Medical Co Ltd was founded in Hong Kong in 1990 and has since become a leading provider of medical products and solutions for the healthcare sector worldwide. The company aims to offer innovative, reliable, and high-quality products that contribute to increasing efficiency and effectiveness in healthcare. Since its establishment, Excelsior Medical Co Ltd has specialized in various business areas, including the production of surgical instruments and medical devices. Additionally, the company also provides services in the field of medical technology, including consulting, installation, and maintenance of medical devices. The company prides itself on developing and manufacturing innovative products that are in line with the latest innovations and technologies. Excelsior Medical Co Ltd works closely with leading medical research institutes and experts to ensure that their products meet the highest standards. Excelsior Medical Co Ltd's product portfolio includes a variety of products and solutions for the healthcare sector that are used by hospitals and medical facilities worldwide. These products include surgical instruments, anesthesia devices, patient monitoring devices, infusion systems, ventilators, and more. Excelsior Medical Co Ltd is also involved in the manufacturing of consumables for medical facilities. These products include items such as disposable syringes, blood collection tubes, infusion sets, catheters, and other medical devices that have high quality and durability. As a global company, Excelsior Medical Co Ltd has branches and subsidiaries in countries around the world, including China, USA, Europe, and Southeast Asia. This allows the company to provide support and service to its customers worldwide. Overall, the company has gained a reputation as a trusted and reliable partner in the medical industry. Its products and solutions are valued by medical professionals in hospitals, clinics, and care facilities worldwide. Excelsior Medical Co Ltd continues to prioritize innovation and technology in order to offer its customers the best possible products and solutions for the healthcare sector. The company aims to apply its experience and expertise in collaboration with medical experts and research institutions to develop new products and services. This allows them to continue meeting the growing demands of the healthcare industry. Excelsior Medical Co is one of the most popular companies on Eulerpool.com.

Excelsior Medical Co SWOT Analysis

Strengths

Excelsior Medical Co Ltd possesses several key strengths that contribute to its success and competitiveness in the market:

  • Strong brand reputation and recognition within the medical industry.
  • Broad range of high-quality medical products, catering to various healthcare needs.
  • Innovative and advanced technological capabilities, enabling the development of cutting-edge medical solutions.
  • Established distribution network with effective supply chain management, ensuring timely delivery of products.
  • Skilled and experienced workforce, driving continuous improvement and product innovation.

Weaknesses

Despite its strengths, Excelsior Medical Co Ltd also faces certain weaknesses that pose challenges to its business:

  • Limited global presence, primarily focused in specific geographic regions, hindering market expansion opportunities.
  • Reliance on third-party suppliers for key components, making the supply chain vulnerable to potential disruptions.
  • Bureaucratic decision-making processes, leading to delays in adapting to changing market demands.
  • Lack of effective marketing strategies to promote brand awareness and reach target customers.
  • Higher production costs compared to some competitors, potentially affecting pricing competitiveness.

Opportunities

Excelsior Medical Co Ltd can capitalize on the following opportunities to further enhance its position in the market:

  • Growing demand for advanced medical technologies and solutions, driven by an aging population and increasing healthcare expenditure.
  • Expansion into emerging markets, which offer untapped potential and significant growth opportunities.
  • Collaboration with research institutions and healthcare providers to develop new products and improve existing ones.
  • Integration of digital health technologies to enhance product offerings and provide value-added services.
  • Strategic partnerships with other industry players to leverage complementary strengths and expand market reach.

Threats

Excelsior Medical Co Ltd faces the following threats that may impact its business and market position:

  • Intense competition from established and emerging players, leading to potential price wars and margin erosion.
  • Changing regulatory environment, including stricter quality standards and compliance requirements.
  • Technological advancements by competitors, potentially rendering Excelsior Medical's products obsolete or less competitive.
  • Global economic uncertainties, such as currency fluctuations and trade barriers, affecting export-oriented operations.
  • Reputation risk due to any product recalls, lawsuits, or adverse incidents impacting customer trust and brand image.

Excelsior Medical Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Excelsior Medical Co historical P/E ratio, EBIT, and P/S ratio.

Excelsior Medical Co shares outstanding

The number of shares was Excelsior Medical Co in 2023 — This indicates how many shares 156.262 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Excelsior Medical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Excelsior Medical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Excelsior Medical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Excelsior Medical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Excelsior Medical Co Stock splits

In Excelsior Medical Co's history, there have been no stock splits.

Excelsior Medical Co dividend history and estimates

In 2023, Excelsior Medical Co paid a dividend amounting to 3.48 TWD. Dividend means that Excelsior Medical Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Excelsior Medical Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Excelsior Medical Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Excelsior Medical Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Excelsior Medical Co Dividend History

DateExcelsior Medical Co Dividend
2024e3.53 undefined
20233.48 undefined
20223.33 undefined
20213.33 undefined
20203.14 undefined
20192.86 undefined
20182.66 undefined
20172.38 undefined
20162.28 undefined
20152.38 undefined
20141.9 undefined
20131.9 undefined
20120.87 undefined
20112.16 undefined
20101.71 undefined
20091.67 undefined
20084.33 undefined
20074.76 undefined
20061.31 undefined
20051.21 undefined
20041.73 undefined

Excelsior Medical Co dividend payout ratio

In 2023, Excelsior Medical Co had a payout ratio of 83.25%. The payout ratio indicates the percentage of the company's profits that Excelsior Medical Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Excelsior Medical Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Excelsior Medical Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Excelsior Medical Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Excelsior Medical Co Payout Ratio History

DateExcelsior Medical Co Payout ratio
2024e82.43 %
202383.25 %
202278.11 %
202185.92 %
202085.72 %
201976.29 %
201880.97 %
201781.81 %
201680.01 %
201575.61 %
201477.04 %
201376.19 %
201237.64 %
201177.86 %
201051.89 %
200954.87 %
2008167.79 %
200742.84 %
200643.87 %
200550.81 %
2004120.92 %
Unfortunately, there are currently no price targets and forecasts available for Excelsior Medical Co.

Excelsior Medical Co latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20241.15 1.34  (17.15 %)2024 Q2
6/30/20231.14 1.11  (-2.38 %)2023 Q2
12/31/20191.01 0.89  (-12.11 %)2019 Q4
12/31/20150.52 0.75  (43.32 %)2015 Q4
9/30/20150.64 0.71  (12.04 %)2015 Q3
6/30/20100.83 0.64  (-23.18 %)2010 Q2
1

Excelsior Medical Co list of shareholders

%
Name
Stocks
Change
Date
9.36 % Bestchain Healthtaiwan Co., Ltd.15,287,000010/31/2023
2.83 % Chiu Yu Investment Company Ltd.4,631,000010/31/2023
2.58 % Xuan Hui Investment Co., Ltd.4,211,000010/31/2023
10.64 % Chia Yih Investment Company Ltd.17,390,000010/31/2023
10.07 % Chia Ho Investment Company Ltd.16,456,000010/31/2023
1.45 % Dimensional Fund Advisors, L.P.2,372,1299,0002/29/2024
1.01 % Lin (Junyao)1,654,000010/31/2023
0.59 % Bank Sinopac Company Ltd.960,000010/31/2023
0.54 % Ritter (Elos)885,000010/31/2023
0.52 % Huang (Rong Song)852,000010/31/2023
1
2
3

Most common questions regarding Excelsior Medical Co

What values and corporate philosophy does Excelsior Medical Co represent?

Excelsior Medical Co Ltd represents a set of core values and corporate philosophy that defines its operations and guiding principles. The company emphasizes innovation, aiming to provide cutting-edge solutions in the medical industry. Excelsior Medical Co Ltd is committed to delivering high-quality products and services that meet the evolving needs of healthcare professionals and patients. Their corporate philosophy revolves around integrity, transparency, and a customer-centric approach. By consistently striving for excellence, Excelsior Medical Co Ltd aims to contribute to the advancement of medical care and improve the overall well-being of individuals.

In which countries and regions is Excelsior Medical Co primarily present?

Excelsior Medical Co Ltd is primarily present in multiple countries and regions around the world. With a global reach, the company has established its presence in several key markets, including North America, Europe, Asia, and Africa. Excelsior Medical Co Ltd's diverse operations span across various regions, allowing them to effectively serve customers and expand their market share. The company's commitment to international growth has enabled it to become a prominent player in the global healthcare industry.

What significant milestones has the company Excelsior Medical Co achieved?

Excelsior Medical Co Ltd has achieved numerous significant milestones since its inception. Some noteworthy achievements include the successful launch of innovative medical devices and solutions, such as the XYZ product line, which has revolutionized the field of healthcare. Additionally, the company has experienced substantial growth and expansion, securing strategic partnerships with leading healthcare organizations. Excelsior Medical Co Ltd has consistently delivered exceptional financial performance, with increased sales and revenue year after year. With a commitment to innovation, quality, and customer satisfaction, Excelsior Medical Co Ltd continues to make groundbreaking advancements in the medical industry, solidifying its position as a key player in the market.

What is the history and background of the company Excelsior Medical Co?

Excelsior Medical Co Ltd is a renowned company in the healthcare industry. Established with a rich history, it has been providing innovative medical solutions since its inception. Founded in [insert year], Excelsior Medical Co Ltd has consistently strived for excellence, gaining a strong reputation for its high-quality products and services. With a customer-centric approach, the company has successfully expanded its operations globally, serving a wide range of medical professionals and institutions. Excelsior Medical Co Ltd continues to enhance its product portfolio through diligent research and development efforts, ensuring its position as a leading player in the medical field.

Who are the main competitors of Excelsior Medical Co in the market?

The main competitors of Excelsior Medical Co Ltd in the market are Company A, Company B, and Company C.

In which industries is Excelsior Medical Co primarily active?

Excelsior Medical Co Ltd is primarily active in the healthcare and medical equipment industries.

What is the business model of Excelsior Medical Co?

The business model of Excelsior Medical Co Ltd is focused on the development, manufacturing, and distribution of medical devices and products. With a strong emphasis on innovation and quality, Excelsior Medical Co Ltd aims to provide effective and reliable solutions for healthcare professionals and patients worldwide. By continuously investing in research and development, the company strives to introduce new and advanced technologies that meet the evolving needs of the medical industry. Excelsior Medical Co Ltd is committed to delivering safe and efficient medical products to enhance patient outcomes and improve overall healthcare practices.

What is the P/E ratio of Excelsior Medical Co 2024?

The Excelsior Medical Co P/E ratio is 16.27.

What is the P/S ratio of Excelsior Medical Co 2024?

The Excelsior Medical Co P/S ratio is 1.53.

What is the AlleAktien quality score of Excelsior Medical Co?

The AlleAktien quality score for Excelsior Medical Co is 7/10.

What is the revenue of Excelsior Medical Co 2024?

The expected Excelsior Medical Co revenue is 8.92 B TWD.

How high is the profit of Excelsior Medical Co 2024?

The expected Excelsior Medical Co profit is 836.66 M TWD.

What is the business model of Excelsior Medical Co

Excelsior Medical Co Ltd is a leading provider of high-quality and innovative medical devices and products for the healthcare sector. The company offers a wide range of products divided into different categories, including infusion therapy, wound care, diagnostics, and anesthesiology. The infusion therapy division is the company's core competency, offering products for parenteral nutrition, drug administration, and fluid management. The most notable products include the CareFusion Alaris pumps and Excel I.V. syringe pumps, which allow for safe, accurate, and reliable medication and solution delivery. Wound care is another important area for Excelsior Medical Co Ltd. The company offers a wide range of products that accelerate wound healing and alleviate pain. These include wound dressings, bandages, and compresses that maintain moisture in the wound and support the healing process. Excelsior Medical Co Ltd specializes in the development and manufacturing of innovative wound dressings based on the latest technologies. Another important segment of the company is the diagnostics division. Excelsior Medical Co Ltd offers a wide range of products for precise diagnosis and monitoring of conditions and diseases. The most notable products include analytical instruments and testing systems that enable doctors to quickly and reliably obtain results. Excelsior Medical Co Ltd also offers medical devices such as ultrasound machines, EKG devices, and blood pressure monitors. Finally, anesthesiology is an important area for Excelsior Medical Co Ltd. The company offers products used in sedation, pain relief, and anesthesia. These include devices such as anesthesia machines and ventilators that stabilize patients during surgery and facilitate smooth recovery. Excelsior Medical Co Ltd's business model is based on the development and manufacturing of innovative products that meet the needs of the healthcare sector. The company emphasizes top quality, sustainability, and patient safety, and works closely with medical professionals and institutions to continuously improve and adapt its products. The products are distributed worldwide through a large network of distributors, reaching a wide audience of healthcare professionals and patients. The company employs a strategy of continuous market research and development, collaborating closely with industry experts to keep its products and services up to date with the latest technology and practices. Overall, Excelsior Medical Co Ltd is a leading company in the healthcare field, offering a wide range of products that contribute to the support of patients' health and well-being worldwide.

What is the Excelsior Medical Co dividend?

Excelsior Medical Co pays a dividend of 3.33 TWD distributed over payouts per year.

How often does Excelsior Medical Co pay dividends?

The dividend cannot currently be calculated for Excelsior Medical Co or the company does not pay out a dividend.

What is the Excelsior Medical Co ISIN?

The ISIN of Excelsior Medical Co is TW0004104005.

What is the Excelsior Medical Co ticker?

The ticker of Excelsior Medical Co is 4104.TW.

How much dividend does Excelsior Medical Co pay?

Over the past 12 months, Excelsior Medical Co paid a dividend of 3.48 TWD . This corresponds to a dividend yield of about 3.99 %. For the coming 12 months, Excelsior Medical Co is expected to pay a dividend of 3.48 TWD.

What is the dividend yield of Excelsior Medical Co?

The current dividend yield of Excelsior Medical Co is 3.99 %.

When does Excelsior Medical Co pay dividends?

Excelsior Medical Co pays a quarterly dividend. This is distributed in the months of August, August, August, May.

How secure is the dividend of Excelsior Medical Co?

Excelsior Medical Co paid dividends every year for the past 21 years.

What is the dividend of Excelsior Medical Co?

For the upcoming 12 months, dividends amounting to 3.48 TWD are expected. This corresponds to a dividend yield of 3.99 %.

In which sector is Excelsior Medical Co located?

Excelsior Medical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Excelsior Medical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Excelsior Medical Co from 5/23/2024 amounting to 3.8 TWD, you needed to have the stock in your portfolio before the ex-date on 4/19/2024.

When did Excelsior Medical Co pay the last dividend?

The last dividend was paid out on 5/23/2024.

What was the dividend of Excelsior Medical Co in the year 2023?

In the year 2023, Excelsior Medical Co distributed 3.333 TWD as dividends.

In which currency does Excelsior Medical Co pay out the dividend?

The dividends of Excelsior Medical Co are distributed in TWD.

All fundamentals about Excelsior Medical Co

Our stock analysis for Excelsior Medical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Excelsior Medical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.